BARDA Awards Covinnovations™ Tech Watch Meeting

This month, Covinnovations™ was awarded a Technical Watch meeting with the Biomedical Advanced Research and Development Authority (BARDA). A Tech Watch meeting is an opportunity for the U.S. government experts to discuss a company’s product or technology and explore potential partnership.  . 

BARDA provides “an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks; pandemic influenza (PI), and emerging infectious diseases (EID). Together with its industry partners, BARDA promotes the advanced development of medical countermeasures to protect Americans and respond to 21st century health security threats.” 

The company was able to present its science behind its proposed COVID treatment, COVI-001, which has demonstrated the potential to directly combat and halt COVID-19 after people have become infected with the disease, particularly those with intense reactions which have been hospitalized and are receiving oxygen. 

Company executives were able to receive valuable feedback from BARDA staff that will facilitate the submission of a future proposal during another funding cycle.  

"We are honored to have been granted this opportunity as it further validates our science, provides valuable feedback and positions us for future success," said CovinnovationsTM founder Dr. Aury Nagy.